Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Journal of Neuro-Oncology
Journal
Overview
Identifiers
View All
Overview
publication venue for
Evaluating the efficacy of a federated AI algorithm in assisting in the detection and segmentation of brain metastases: limitations and opportunities
. 176.
2025
Assessment of outcomes and machine Learning-based models to predict local failure risk following stereotactic radiosurgery for small brain metastases
. 174:635-643.
2025
Temporospatial tumor dynamic changes in glioblastoma during radiotherapy
. 174:493-501.
2025
Integrating a novel tablet-based digital neurocognitive assessment tool in brain metastases patients
. 174:121-129.
2025
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis
. 169:105-117.
2024
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas
. 155:297-306.
2021
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
. 155:363-372.
2021
Early imaging marker of progressing glioblastoma:
a window of opportunity
. 148:629-640.
2020
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201
. 145:97-105.
2019
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma
. 144:205-210.
2019
NRG brain tumor specialists consensus guidelines for glioblastoma contouring
. 143:157-166.
2019
Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study
. 140:341-349.
2018
Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus
. 140:421-426.
2018
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02
. 136:79-86.
2018
Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation
. 134:331-338.
2017
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas
. 133:589-594.
2017
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
. 131:193-199.
2017
Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study
. 131:105-115.
2017
Clinical ramifications of "genomic staging" of low-grade gliomas
. 129:195-199.
2016
What predicts early volumetric edema increase following stereotactic radiosurgery for brain metastases?
. 127:303-311.
2016
A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas
. 127:127-135.
2016
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
. 126:309-316.
2016
CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933
. 126:327-336.
2016
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
. 125:191-195.
2015
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131
. 124:413-420.
2015
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study
. 122:409-417.
2015
Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort
. 120:431-440.
2014
Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery
. 116:187-193.
2014
CMYC expression in infiltrating gliomas: Associations with IDH1 mutations, clinicopathologic features and outcome
. 115:249-259.
2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
. 112:467-472.
2013
A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
. 111:33-39.
2013
Hypoxia-inducible factor-1-regulated protein expression and oligodendroglioma patient outcome: Comparison with established biomarkers and preoperative UCSF low-grade scoring system
. 108:459-468.
2012
Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases
. 108:141-146.
2012
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
. 106:147-153.
2012
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤6 brain metastases: a multi-institutional phase II trial
. 105:301-308.
2011
Age as an independent prognostic factor in patients with glioblastoma: a radiation therapy oncology group and American College of Surgeons National Cancer Data Base comparison
. 104:351-356.
2011
Current practices of driving restriction implementation for patients with brain tumors
. 103:641-647.
2011
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
. 96:211-217.
2010
The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
. 96:71-83.
2010
The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline
. 96:85-96.
2010
Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03
. 95:247-257.
2009
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas
. 91:183-189.
2009
Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults
. 89:313-337.
2008
A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group Study (E2393)
. 47:145-152.
2000
The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: Report of a synergistic effect between topotecan and radiation
. 30:1-6.
1996
ACUTE CHANGES IN GLUCOSE-UPTAKE AFTER TREATMENT - THE EFFECTS OF CARMUSTINE (BCNU) ON HUMAN GLIOBLASTOMA-MULTIFORME
. 15:57-66.
1993
MENINGEAL HEMANGIOPERICYTOMA - DEFINING THE ROLE FOR RADIATION-THERAPY
. 14:277-287.
1992
Distribution of brain metastases in relation to the hippocampus
2008
Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma
2005
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice
2024
Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma
2015
The role of upfront radiation therapy for brain metastases in the era of CNS-active systemic therapies: a narrative review of clinical trial design and lessons learned
2025
Radiotherapeutic advances in the management of glioblastoma
2024
Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma
2016
Fractionated radiotherapy for intracranial meningiomas
2010
Opportunities for clinical research in meningioma
2010
The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics
2010
The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
2010
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
2010
The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
2010
The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
2010
The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
2010
State of the art: the evolving role of RT in combined modality therapy for GBM
2017
The role of radiation in treating glioblastoma: here to stay
2017
Pharmacokinetic analysis of etoposide distribution after administration directly into the fourth ventricle in a piglet model.
2010
Erratum: The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline (Journal of Neuro-Oncology DOI: 10.1007/s11060-009-0073-4)
2010
Identifiers
International Standard Serial Number (ISSN)
0167-594X
Electronic International Standard Serial Number (EISSN)
1573-7373
